M&RP Recent Publications
Below are links to articles recently published regarding measles and rubella (listed first) as well as for articles of interest for other immunization (listed further below.)
Bibliography Measles Citations, First Quarter of 2025
-
A journey worth taking: global eradication of measles, rubella and congenital rubella syndrome.
Andrus JK, Durrheim DN.
Expert Rev Vaccines. 2025 Dec;24(1):173-174.
doi: 10.1080/14760584.2025.2476535.
- Measles is surging in the US: how bad could it get?
-
Measles in Texas: waning vaccination and a stark warning for public health.
Kuppalli K, Perl TM.
Lancet Infect Dis. 2025 Mar 11:S1473-3099(25)00162-8.
doi: 10.1016/S1473-3099(25)00162-8.
-
Measles seroprevalence in infants under nine months of age in low- and middle-income countries: a systematic review and meta-analysis.
Ong DS, von Mollendorf C, Mulholland K, Do LAH.
J Infect Dis. 2025 Apr 3:jiaf177.
doi: 10.1093/infdis/jiaf177.
-
Global Resurgence of Measles: Turning the Tide through a Bold Agenda for Prevention and Control.
Mpabalwani E, Ippolito G, Asogun D, Aklillu E, Maeurer M, Shan Lee S, Zumla A. Int
J Infect Dis. 2025 Mar 31;155:107901.
doi: 10.1016/j.ijid.2025.107901.
-
Rubella and measles: The beginning of the endgame.
Ferrari MJ, Moss WJ.
Science. 2025 Apr 4;388(6742):32-34.
doi: 10.1126/science.adv7588.
-
Vaccines Matter: Measles and Its Complications.
Kuo C.
Pediatrics. 2025 Apr 22.
doi: 10.1542/peds.2025-071622.
When I was seven, my eldest brother, Sammy, was diagnosed with subacute sclerosing panencephalitis (SSPE) – a sequela of measles infection. He rapidly deteriorated into a vegetative state. Looking back, the bulk of my childhood consisted of mixing nasogastric feeds for him …
- Measles: Second child dies in Texas as RFK Jr finally recommends vaccination.
-
Uptake of second dose measles containing vaccine and associated factors among children aged 24-35 months in central Ethiopia: a community based cross-sectional study.
Mulatu A, Tsega Y, Cherie N, Kasaye MD, Mekonen AM.
BMC Public Health. 2025 Apr 21;25(1):1470.
doi: 10.1186/s12889-025-22750-z.
-
Why now? The measles controversy.
Branda F, Scarpa F, Ciccozzi M.
Lancet Infect Dis. 2025 Apr 16:S1473-3099(25)00239-7.
doi: 10.1016/S1473-3099(25)00239-7.
- Measles Cases in European Region Highest in More Than 25 Years.
-
Global, regional, and national trends of measles burden and its vaccination coverage among children under five years old: an updated systematic analysis from the Global Burden of Disease study 2021.
Chen W, Du M, Deng J, Liu M, Liu J. Int
J Infect Dis. 2025 Apr 15:107908.
doi: 10.1016/j.ijid.2025.107908.
-
Fitting dynamic measles models to subnational case notification data from Ethiopia: Methodological challenges and key considerations.
Sbarra AN, Haeuser E, Kidane S, Abate A, Abebe AM, Ahmed M, Alemayehu T, Amsalu E, Aravkin AY, Asgedom AA, Bayleyegn N, Dagnew M, Demisse B, Etafa W, Fetensa G, Gebremeskel TG, Geremew H, Gizaw AT, Hunde GA, Meles HN, Migbar S, Nguyen JQ, Nigussie E, Ramshaw RE, Rolfe S, Sahiledengle B, Shalev N, Solomon Y, Tesfaye L, Yesera GE, Jit M, Mosser JF.
PLoS Comput Biol. 2025 Apr 16;21(4):e1012922.
doi: 10.1371/journal.pcbi.1012922. eCollection 2025 Apr.
- Timeliness of the second dose of measles-containing vaccine uptake and its determinants among children aged 24-36 months in Gondar City, Northwest Ethiopia, 2023: Community-based cross-sectional study design.
-
Integrated serological surveillance for neglected tropical diseases, vaccine-preventable diseases, and arboviruses in Samoa, 2018.
Lawford HLS, Mayfield HJ, Sam FA, Viali S, Kamu T, Thomsen R, Lau CL.
Sci Rep. 2025 Apr 12;15(1):12667.
doi: 10.1038/s41598-025-96769-y. PMID: 40221582 Free PMC article.
-
Measles: the urgent need for global immunisation and preparedness.
Kuppalli K, Omer SB.
Lancet. 2025 Apr 8:S0140-6736(25)00675-0.
doi: 10.1016/S0140-6736(25)00675-0.
-
The quality of measles outbreak investigation report, how can it bridge the gap and help to fulfill the goal of measles elimination?
Rahimi E, Ghaderi E, Mostafavi E, Karami M.
BMC Infect Dis. 2025 Apr 10;25(1):496.
doi: 10.1186/s12879-025-10887-6.
-
What's Old Is New Again: Measles.
Li CN, Kaplan SL, Edwards KM, Marshall GS, Parker S, Healy CM.
Pediatrics. 2025 Apr 11.
doi: 10.1542/peds.2025-071332.
- Approaches for MMR Vaccination During a Measles Outbreak and Evolving Domestic Attitudes.
-
Infection prevention and control for measles in healthcare settings.
Frantzis I, Acker KP, Benjamin EO, Pato R, Legall S, Singh HK, Saiman L.
Infect Control Hosp Epidemiol. 2025 Apr 8:1-8.
doi: 10.1017/ice.2025.49.
-
Immunogenicity and safety of a measles and rubella-containing vaccine at age 6 and 9 months in Bangladesh: an open-label, randomised trial.
Sayi TS, Sharapov UM, Matson Z, Coughlin MM, Crooke SN, An Q, Knapp JK, Aziz AB, Yunus M, Haque W, Rana S, Khan MAF, Alexander JP, Kretsinger K, Rota PA, Zaman K, Anand A.
Lancet Child Adolesc Health. 2025 May;9(5):306-314.
doi: 10.1016/S2352-4642(25)00090-2.
-
Safety and immunogenicity of Biological E's typhoid conjugate vaccine TYPHIBEV(R) concomitantly administered with measles rubella vaccine: a phase IV prospective, multicenter study.
Thuluva S, Matur RV, Gunneri S, Mogulla R, Dhar C, Yerroju V, Balne N, Chakravarthy BS, Narang M, Mahantshetti NS, Pandey AK.
IJID Reg. 2025 Feb 25;15:100611.
doi: 10.1016/j.ijregi.2025.100611. eCollection 2025 Jun.
-
Measles-mumps-rubella-vaccination at 6 months of age induces measles-specific T cell responses: a randomized controlled trial.
Buus S, Vittrup DM, Schmidt JD, Jensen A, Stryhn A, Stensballe LG.
Front Immunol. 2025 Mar 17;16:1546253.
doi: 10.3389/fimmu.2025.1546253.
-
Analysis of Age Appropriate Measles Immunisation among the Eligible Children in India: A Cross-Sectional Analysis of National Family Health Survey-5.
Debnath A, Roy N, Roy D, Sarma M, Roy D, Das K, Deb D.
Indian J Community Med. 2025 Jan-Feb;50(1):99-107.
doi: 10.4103/ijcm.ijcm_406_23.
-
Immunogenicity and safety of measles-mumps-rubella vaccine delivered by the aerosol, intradermal and intramuscular routes in previously vaccinated young adults: a randomized controlled trial protocol.
Saha S, Millier M, Samaranayaka A, Edmonds L, Best E, Ussher J, Anglemyer A, Lee J, Tatley M, Cutts F, van Binnendijk R, McIntyre P.
PLoS One. 2025 Mar 21;20(3):e0318893.
doi: 10.1371/journal.pone.0318893.
-
Impact of Mandatory Measles Vaccination on Coverage in Italy and the European Union: an observational study.
Gaeta M, Fugazza S, Carbone M, Marjin C, Parrini A, Raso E, Viviani L, Odone A.
Ann Ig. 2025 May-Jun;37(3):378-383.
doi: 10.7416/ai.2025.2679.
-
Revising US MMR Vaccine Recommendations Amid Changing Domestic Risks.
Rader B, Walensky RP, Rogers WS, Brownstein JS.
JAMA. 2025 Apr 8;333(14):1201-1202.
doi: 10.1001/jama.2025.3867. PMID: 40085113
- Amid Texas Measles Outbreak, Clinicians Struggle to Offset Increasing Vaccine Hesitancy.
-
Sero-epidemiology of measles immunoglobulin G antibodies among newborns from South-East Asia and sub-Saharan Africa: an observational, multicenter study.
Bokop C, Dhar N, Izu A, Ali MM, Akaba G, Barsosio HC, Berkley JA, Beck MM, Chaka TE, Cutland CL, Dorji P, Keita AM, Lema FB, Medugu N, Mwarumba S, Mwakio S, Obaro S, Olateju EK, Sahni RD, Saha SK, Santhanam S, Sharma R, Sigaúque B, Simoes EAF, Sow SO, Tapia MD, Veeraraghavan B, Madhi SA, Kwatra G.
Int J Infect Dis. 2025 May;154:107882.
doi: 10.1016/j.ijid.2025.107882.
-
Low levels of pertussis- and measles-specific IgG antibodies in 6-week-old HIV-exposed and -unexposed Malawian infants: implications for vaccination strategies and role of long term HIV therapy.
Baroncelli S, Galluzzo CM, Orlando S, Luhanga R, Mphwere R, Kavalo T, Amici R, Floridia M, Andreotti M, Ciccacci F, Marazzi MC, Giuliano M.
J Trop Pediatr. 2025 Feb 5;71(2):fmaf013.
doi: 10.1093/tropej/fmaf013. PMID: 40064194
-
Facts and myths about measles.
The Lancet Infectious Diseases.
Lancet Infect Dis. 2025 Apr;25(4):357.
doi: 10.1016/S1473-3099(25)00164-1.
-
The long term benefits of the measles vaccine in Mexico.
Atwood A, Pearlman S.
J Health Econ. 2025 Feb 19;101:102974.
doi: 10.1016/j.jhealeco.2025.102974.
-
Trend of Measles Outbreak in Yemen From January 2020 to August 2024.
Edrees WH, Al-Shehari WA, Al-Haddad OS, Al-Halani AA, Alrahabi LM.
Int J Gen Med. 2025 Mar 1;18:1203-1214.
doi: 10.2147/IJGM.S508189.
- Robert F Kennedy Jr offers qualified support for MMR vaccine as measles spreads across US and Canada.
-
Measles outbreak challenges Trump's public health vision.
Furlow B.
Lancet Respir Med. 2025 Feb 26:S2213-2600(25)00075-X.
doi: 10.1016/S2213-2600(25)00075-X.
- Daily briefing: An unvaccinated child is first US measles death in a decade.
-
Seroprevalence of measles antibodies in women born between 1985 and 1999 in metropolitan city in India: a cross-sectional study.
Hadaye R, Chandanshive PD, Khan N.
BMJ Public Health. 2024 Dec 11;2(2):e001417.
doi: 10.1136/bmjph-2024-001417.
-
Spatial analysis of measles cases and vaccination coverage in the Somali region, eastern Ethiopia.
Muse AI, Kayat MY, Aden MH, Shuramu JB, Mohammed S, Ibrahim MA, Berhe BM, Kalinle AA, Abdilahi SA.
Front Epidemiol. 2025 Feb 10;5:1498750.
doi: 10.3389/fepid.2025.1498750.
- Measles Vaccination Coverage and Anti-Measles Herd Immunity Levels in the World and WHO Regions Worsened from 2019 to 2023.
-
Factors Associated with Timely First-Dose Pentavalent and Measles-Rubella Vaccination: A Cross-Sectional Study in East New Britain, Papua New Guinea.
Dalton M, Pomat W, Danchin M, Homer CSE, Sanderson B, Kiromat P, Robinson LJ, Scoullar MJL, Melepia P, Laman M, James HA, Stanley E, Waramin E, Vaccher S.
Vaccines (Basel). 2025 Feb 4;13(2):156.
doi: 10.3390/vaccines13020156.
-
Missed Measles Immunisations Places Individuals and Communities at Risk: The Equity Argument for Including Measles in Under-Immunised Definitions.
Vaccher S, Laman M, Danchin M, Angrisano F, Morgan C.
Vaccines (Basel). 2025 Jan 22;13(2):108.
doi: 10.3390/vaccines13020108.
- Measles: Texas outbreak spreads to New Mexico.
-
A population-based measles serosurvey in Mexico: Implications for re-emergence.
Carnalla M, Gaspar-Castillo C, Dimas-González J, Aparicio-Antonio R, Justo-Berrueta PS, López-Martínez I, Shamah-Levy T, Lazcano-Ponce E, Barrientos-Gutiérrez T, Alpuche-Aranda CM, Martínez-Barnetche J.
Vaccine. 2025 Apr 2;51:126886.
doi: 10.1016/j.vaccine.2025.126886.
-
Measles outbreak investigation in Kakumiro District, Uganda, February-May 2024.
Okiror Okello E, Migisha R, Ampaire I, Nsubuga F, Nalwanga J, Kwizera P, Okello PE, Bulage L, Kwesiga B, Ario AR.
Discov Public Health. 2025;22(1):52.
doi: 10.1186/s12982-025-00446-4. Epub 2025 Feb 14.
-
Outbreak of Measles in Southern Switzerland: Is It Time to Put Stricter Rules on Vaccination?
Bongiovanni M, Nobile A, Merlani G, Ramponi N, Bellini P, Bernasconi E.
J Med Virol. 2025 Feb;97(2):e70244.
doi: 10.1002/jmv.70244.
-
Evaluation of Measles Cases in a Province in South-Eastern Turkey Receiving Migration From Syria.
Orhan Ö, Solmaz M, Talay MN.
Acta Paediatr. 2025 May;114(5):1051-1056.
doi: 10.1111/apa.70008.
-
Impact of measles vaccination strategies on vaccination rates in low-income and middle-income countries: a systematic review and meta-analysis.
Yitbarek K, Mahimbo A, Bobo FT, Woldie M, Sheel M, Frawley J, Hayen A. BMJ Glob Health.
2025 Feb 10;10(2):e016647.
doi: 10.1136/bmjgh-2024-016647.
PMID: 39929538
-
Epidemiology of measles clusters/outbreaks during 2016-2017 in Oman.
Kurubarahalli Patel P, Al-Rawahi B, Al-Farsi N, Al-Mahruqi S, Al-Busaidy A, Al-Abri S, Al-Maani A.
IJID Reg. 2024 Dec 20;14:100552.
doi: 10.1016/j.ijregi.2024.100552.
-
Revealing trends in measles immunity during periods of varying measles circulation in Madagascar.
Menezes A, Hay JA, Razafindratsimandresy R, Randriamanantena AH, Yang L, Héraud JM, Cauchemez S, Wesolowski A, Grenfell B, Graham AL, Metcalf CJE.
Am J Epidemiol. 2025 Jan 20:kwaf005.
doi: 10.1093/aje/kwaf005.
-
Revaccination and its efficacy against hepatitis B virus, measles, mumps, and rubella in children after allogeneic hematopoietic stem cell transplantation.
Cai J, Chen W, Zhang H, Chen J, Fei Y, Cao Q.
Chin Med J (Engl). 2025 Jan 17;138(5):604-6.
doi: 10.1097/CM9.0000000000003462.
-
Parental Factors Associated With Measles-Mumps-Rubella Vaccination in US Children Younger Than 5 Years.
Zhou EG, Cantor J, Gertz A, Elbel B, Brownstein JS, Rader B.
Am J Public Health. 2025 Mar;115(3):369-373.
doi: 10.2105/AJPH.2024.307912.
-
A systematic review and meta-analysis of adverse events following measles-containing vaccines in infants less than 12 months of age.
Vittrup DM, Charabi S, Jensen A, Stensballe LG.
Vaccine. 2025 Feb 15;47:126687.
doi: 10.1016/j.vaccine.2024.126687.
-
Vaccination against measles-mumps-rubella and rates of non-targeted infectious disease hospitalisations: Nationwide register-based cohort studies in Denmark, Finland, Norway, and Sweden.
Gehrt L, Möller S, Englund H, Laake I, Nieminen H, Feiring B, Lahdenkari M, Palmu AA, Trogstad L, Benn CS, Sørup S.
J Infect. 2025 Feb;90(2):106365.
doi: 10.1016/j.jinf.2024.106365.
-
Post-exposure prophylaxis for the prevention of measles: A systematic review.
Montroy J, Yan C, Khan F, Forbes N, Krishnan R, Tunis M, Salvadori MI.
Vaccine. 2025 Feb 15;47:126706.
doi: 10.1016/j.vaccine.2025.126706.
-
Geospatial Variation in Vaccination Coverage and Zero-Dose Prevalence at the District, Ward and Health Facility Levels Before and After a Measles Vaccination Campaign in Nigeria.
Utazi CE, Olowe ID, Chan HMT, Dotse-Gborgbortsi W, Wagai J, Umar JA, Etamesor S, Atuhaire B, Fafunmi B, Crawford J, Adeniran A, Tatem AJ.
Vaccines (Basel). 2024 Nov 21;12(12):1299.
doi: 10.3390/vaccines12121299.
Bibliography of Citations on Routine Immunization, First Quarter of 2025
-
Strengthening health security through routine vaccination policy: A comprehensive analysis of childhood vaccination laws across 194 countries.
Weets CM, Wilson R, Swadley H, Katz R.
Vaccine. 2025 Apr 15;54:127121.
doi: 10.1016/j.vaccine.2025.127121.
-
Association of gross domestic product with equitable access to childhood vaccines in 195 countries: a systematic review and meta-analysis.
Dinga JN, Akinbobola JS, Afolayan FID, Njoh AA, Kassa T, Lazarus DD, Dieye Y, Kassa GM, Duedu KO, Tshifhiwa N, Oumouna M; AfVANET -African Vaccinology Network.
BMJ Glob Health. 2025 Jan 19;10(1):e015693.
doi: 10.1136/bmjgh-2024-015693.
-
The Addis Declaration on Immunization: Assessing the Effectiveness and Efficiency of Immunization Service Delivery Systems in Africa as of the End of 2023.
Mboussou F, Wiysonge CS, Farham B, Bwaka A, Wanyoike S, Petu A, Ndiaye S, Bita Fouda A, Ticha JM, Amani A, Obiang R, Bagayoko MM, Impouma B.
Vaccines (Basel). 2024 Dec 27;13(1):13.
doi: 10.3390/vaccines13010013.PMID: 39852792 Free PMC article.
-
Coverage of complete basic childhood vaccination and its variation by basic characteristics among children aged 12-23 months in 41 low- and middle-income countries: A Meta-analysis of demographic and health survey reports between 2015 and 2025.
Tamir TT, Tekeba B, Techane MA, Alemu TG, Wubneh CA, Wassie YA.
Vaccine. 2025 Mar 12;54:127019.
doi: 10.1016/j.vaccine.2025.127019.
-
Strengthening health security through routine vaccination policy: A comprehensive analysis of childhood vaccination laws across 194 countries.
Weets CM, Wilson R, Swadley H, Katz R.
Vaccine. 2025 Apr 15;54:127121.
doi: 10.1016/j.vaccine.2025.127121.
-
Association of gross domestic product with equitable access to childhood vaccines in 195 countries: a systematic review and meta-analysis.
Dinga JN, Akinbobola JS, Afolayan FID, Njoh AA, Kassa T, Lazarus DD, Dieye Y, Kassa GM, Duedu KO, Tshifhiwa N, Oumouna M; AfVANET -African Vaccinology Network.
BMJ Glob Health. 2025 Jan 19;10(1):e015693.
doi: 10.1136/bmjgh-2024-015693.
-
The Addis Declaration on Immunization: Assessing the Effectiveness and Efficiency of Immunization Service Delivery Systems in Africa as of the End of 2023.
Mboussou F, Wiysonge CS, Farham B, Bwaka A, Wanyoike S, Petu A, Ndiaye S, Bita Fouda A, Ticha JM, Amani A, Obiang R, Bagayoko MM, Impouma B.
Vaccines (Basel). 2024 Dec 27;13(1):13.
doi: 10.3390/vaccines13010013.PMID: 39852792 Free PMC article.
- The power of story: what Victorian novels can teach us about public health.
-
Vaccination coverage and its associated factors among children under-5 in Somalia.
Hassan MS, Abdulla F, Hossain M.
BMC Public Health. 2025 Mar 13;25(1):997.
doi: 10.1186/s12889-025-21529-6.
-
Childhood vaccination coverages in rural Guinea-Bissau before and during the early COVID-19 pandemic, a cohort study.
Vedel JO, Furtado O, Almeida LL, Nehal KR, Nanque LM, Damerow SM, Bassat Q, Jensen AKG, Fisker AB.
Vaccine. 2025 Mar 12;54:127011.
doi: 10.1016/j.vaccine.2025.127011.
-
Orchestrating a Successful Veto Campaign Against a Detrimental School Immunization Bill.
Bloom Emrick B, Copenhaver EA, Gerlach J, Jeffrey JL, Lauffer AM, Martin K, Mousattat Y, Costello LM.
Pediatrics. 2025 Apr 1;155(4):e2024068983.
doi: 10.1542/peds.2024-068983.
-
Prevalence and determinants of child immunization coverage in Ethiopia: Evidence from the 2019 mini-demographic and health survey.
Gebrehiwot GT, Tilahun M, Gebrehiwot H, Kahsay H, Gebregziabher G, Haddis S, Tesfay M, Alemseged G, Alemseged G, Kalayu M, Yisfa G, Alemu M, Bidre HB, Teklue T.
Hum Vaccin Immunother. 2025 Dec;21(1):2478707.
doi: 10.1080/21645515.2025.2478707.
-
Effect of a proactive childhood vaccination reminder system on vaccination coverage and uptake in Denmark: A register-based cohort study.
Funk T, Nørgaard SK, Hallundbæk L, Grau J, Ethelberg S, Valentiner-Branth P, Andersen PH.
Vaccine. 2025 Mar 26;54:126934.
doi: 10.1016/j.vaccine.2025.126934. Online ahead of print. PMID: 40147273 Free article.
-
Using an Electronic Immunization Registry (Aplikasi Sehat IndonesiaKu) in Indonesia: Cross-Sectional Study.
Aisyah DN, Utami A, Rahman FM, Adriani NH, Fitransyah F, Endryantoro MTA, Hutapea PY, Tandy G, Manikam L, Kozlakidis Z.
Interact J Med Res. 2025 Mar 27;14:e53849.
doi: 10.2196/53849.
-
Path to full immunisation coverage, role of each vaccine and their importance in the immunisation programme: a cross-sectional analytical study of India.
Dhalaria P, Kumar P, Kapur S, Singh AK, Verma AK, Agarwal D, Tripathi B, Taneja G.
BMJ Public Health. 2025 Mar 23;3(1):e001290.
doi: 10.1136/bmjph-2024-001290.
-
Identification of potential vaccines for use with microarray patches in low- and middle-income countries: An assessment from the Vaccine Innovation Prioritisation Strategy Alliance.
Vinusha V, Girish C.Naunyn Schmiedebergs
Arch Pharmacol. 2024 Aug 23.
doi: 10.1007/s00210-024-03368-1. Online ahead of print.PMID: 39177789 Review.
-
Childhood vaccination trends among the Maasai nomadic pastoralists: Insights from a community-based vaccine registry in Kenya.
Odhiambo JN, Dolan CB, Thompson E, O’Neill K, Sankok J, Kimani R.
PLOS Glob Public Health. 2025 Mar 25;5(3):e0004077.
doi: 10.1371/journal.pgph.0004077.
-
The role of health systems in shaping vaccine decisions: Insights from Italy, Mexico, the United Kingdom, and the United States.
Arsenault C, Ravishankar S, Lewis T, Armeni P, Croke K, Doubova SV, McKee M, Tarricone R, Kruk ME.
Vaccine. 2025 Apr 16;54:127134.
doi: 10.1016/j.vaccine.2025.127134.
-
Child immunization data quality in Rwanda: an assessment of routine health information system data.
Uwera T, Frøen JF, Papadopoulou E, Rukundo E, Sibomana H, Muhire A, Tumusiime DK, Venkateswaran M.
Arch Public Health. 2025 Apr 9;83(1):97.
doi: 10.1186/s13690-025-01583-7.
-
India's Universal Immunization Program: A Review of Successes, Challenges, and Future Directions.
Jacob John T, Kompithra RZ.
Indian J Med Microbiol. 2025 Apr 17:100854.
doi: 10.1016/j.ijmmb.2025.100854.
-
Putting governance into practice: The engagement of private health sector for Universal Health Coverage and health security.
Balkhy H, Aylward B.
East Mediterr Health J. 2024 Dec 18;30(12):807-809.
doi: 10.26719/2024.30.12.807.
-
Quantum vaccinology: A new science and epistemological abstraction framework for developing new vaccines and understanding the generation of the immune response.
Poland GA, de la Fuente J.
Vaccine. 2025 Feb 6;46:126641.
doi: 10.1016/j.vaccine.2024.126641.
-
Parental vaccine hesitancy: Recent evidences support the need to implement targeted communication strategies.
Cagnotta C, Lettera N, Cardillo M, Pirozzi D, Catalán-Matamoros D, Capuano A, Scavone C.
J Infect Public Health. 2025 Feb;18(2):102648.
doi: 10.1016/j.jiph.2024.102648. Epub 2025 Jan 3.
-
Evaluation of Integrated Child Health Days as a Catch-Up Strategy for Immunization in Three Districts in Uganda.
Farahani M, Tindyebwa T, Sugandhi N, Ward K, Park Y, Bakkabulindi P, Kulkarni S, Wallace A, Biraro S, Wibabara Y, Chung H, Reid GA, Alfred D, Atugonza R, Abrams EJ, Igboh LS.
Vaccines (Basel). 2024 Nov 29;12(12):1353.
doi: 10.3390/vaccines12121353.
-
Leveraging Data from a Provincial Electronic Immunization Registry to Analyze Immunization Coverage, Timeliness, and Defaulters Among 8.8 Million Children from the 2018 to 2023 Birth Cohorts in Sindh Province, Pakistan.
Miraj F, Iftikhar S, Siddique M, Dharma VK, Shah MT, Siddiqi DA, Chandir S.
Vaccines (Basel). 2024 Nov 26;12(12):1327.
doi: 10.3390/vaccines12121327.
-
Implications of conflict on vaccination in the Sahel region.
Sabahelzain MM, Dwyer H, Abimbola S, Leask J.
BMJ Glob Health. 2025 Jan 30;10(1):e016496.
doi: 10.1136/bmjgh-2024-016496.
-
Microarray patches likely to reduce the operational costs of immunization: A Monte Carlo simulation study.
Hagedorn B, Frey K, Scarna T, El Sheikh F.
Vaccine. 2025 Mar 19;50:126840.
doi: 10.1016/j.vaccine.2025.126840.
-
Advancing local manufacturing capacities for vaccines within Africa - Opportunities, priorities and challenges.
Doua J, Ndembi N, Auerbach J, Kaseya J, Zumla A.
Vaccine. 2025 Mar 19;50:126829.
doi: 10.1016/j.vaccine.2025.126829.
-
A qualitative process evaluation of community-based participatory research and human-centered design in the 'Let's talk about vaccines' approach in Mozambique and Malawi.
Shuro L, Lawrence E, De Man J, Knight L, Schneider H, Tabana H.
Res Involv Engagem. 2025 Feb 21;11(1):11.
doi: 10.1186/s40900-025-00677-4.
-
Full vaccination coverage for children aged 12-23 months in Madagascar: Analysis of the 2021 Demographic and Health Survey.
Wongnaah FG, Aboagye RG, Osborne A, Seidu AA, Ahinkorah BO.
BMC Public Health. 2025 Feb 21;25(1):727.
doi: 10.1186/s12889-025-21397-0.
-
Assessing the resilience of child immunisation programmes using geospatial modelling and interrupted time series analysis in Ethiopia and Kenya amidst the COVID-19 pandemic: tracking coverage and identifying key challenges.
Mankhwala CS, Chifungo C, Mzembe T, Ngwira T, Peterson MB, Khundi M, Madise NJ, Chipeta MG. BMJ Public Health. 2024 Jul 26;2(1):e000857.
doi: 10.1136/bmjph-2023-000857.
-
How is the restrictive vaccine vial opening policy of the childhood vaccination programme experienced by health care workers and health facility users? A qualitative study in rural Guinea-Bissau.
Vedel JO, Martins JSD, Borges IDS, Bassat Q, Fisker AB, Maixenchs M.
Public Health. 2025 Apr 3;242:332-339.
doi: 10.1016/j.puhe.2025.02.038.
-
Zero-dose children in Latin America: analysis of the problem and possible solutions.
Avila-Aguero ML, Brenes-Chacon H, Melgar M, Becerra-Posada F, Chacon-Cruz E, Gentile A, Ospina M, Sandoval N, Sanwogou J, Urena A, Valenzuela MT, Morice A.
F1000Res. 2025 Jan 27;13:1060.
doi: 10.12688/f1000research.155286.2.
Partnership Alliance
The mark 'CDC' is owned by the US Dept. of Health and Human Services and is used with permission. Use of this logo is not an endorsement by HHS or CDC of any particular product, service, or enterprise. CDC's logo and work with the Partnership is not connected to any fundraising aspect of the organization.
Follow Us
Prelude Version 2.3.2